Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Neurogenetics ; 9(3): 173-82, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18563459

RESUMEN

Limb-girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive disorder caused by mutations in the CAPN3 gene. Its definitive diagnosis is laborious, since the clinical phenotype is often similar to other types of muscular dystrophy and since the CAPN3 gene encompasses a large genomic region with more than 300 pathogenic mutations described to date. In fact, it is estimated that nearly 25% of the cases with a phenotype suggestive of LGMD2A do not have mutations in the CAPN3 gene and that, in up to 22% of the cases, only one mutation is identified. In the present work, we have characterised CAPN3 messenger RNA (mRNA) expression in peripheral blood, and we have performed a retrospective diagnostic study with 26 LGMD2A patients, sequencing a transcript of CAPN3 present in white blood cells (WBCs). The 25% of the mutations presented in this paper (7/28) act modifying pre-mRNA splicing of the CAPN3 transcript, including the first deep-intronic mutation described to date in the CAPN3 gene. Our results determine that the sequencing of CAPN3 transcripts present in WBCs could be applied as a new approach for LGMD2A diagnosis. This method improves and simplifies diagnosis, since it combines the advantages of mRNA analysis in a more accessible and rapidly regenerated tissue. However, the lack of exon 15 in the CAPN3 isoforms present in blood, and the presence of mRNA degradation make it necessary to combine mRNA and DNA analyses in some specific cases.


Asunto(s)
Calpaína/sangre , Calpaína/genética , Leucocitos/enzimología , Proteínas Musculares/sangre , Proteínas Musculares/genética , Distrofia Muscular de Cinturas/enzimología , Distrofia Muscular de Cinturas/genética , Adolescente , Adulto , Empalme Alternativo , Secuencia de Bases , Estudios de Casos y Controles , Niño , Análisis Mutacional de ADN , ADN Complementario/genética , Femenino , Humanos , Isoenzimas/sangre , Isoenzimas/genética , Masculino , Persona de Mediana Edad , Músculos/enzimología , Distrofia Muscular de Cinturas/clasificación , Distrofia Muscular de Cinturas/diagnóstico , Mutación , ARN Mensajero/sangre , ARN Mensajero/genética , Estudios Retrospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Adulto Joven
2.
Lab Anim ; 42(1): 19-25, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18348763

RESUMEN

Rat serum or plasma creatine kinase (CK) activity is widely used to evaluate myopathic processes, to test the myotoxicity of different drugs, or to analyse the benefits of emerging gene therapies in some neuromuscular disorders. However, great variability is found in this determination. The aim of this study has been to control some factors of variation in order to reduce variability and increase the reproducibility of analytical data. 8-10-week-old Wistar-Han rats were used. The study consisted of four sequential phases. Phase I aimed to analyse the effect of ether and isoflurane as anaesthetic drugs. The objective of Phase II was to evaluate bleeding rats via retro-orbital sinus vs. tail vein. Phases III and IV were designed as two separate, repeated measure experiments on two factors: habituation to laboratory handling procedures in Phase III and gender in Phase IV. The repeated factor was the storage temperature of blood sample prior to centrifugation. Ether did not significantly increased the CK value. Using isoflurane, getting rats accustomed to laboratory handling procedures and whole blood refrigeration prior to centrifugation and serum separation resulted in statistically significant reduction in CK value and variability. Male rats showed significantly higher values than female rats. In the light of our findings, CK value and variability in rats may be minimized by choosing tail vein as site of bleeding, getting rats accustomed to laboratory handling procedures and maintaining whole blood refrigerated until centrifugation and serum separation.


Asunto(s)
Creatina Quinasa/metabolismo , Enfermedades Neuromusculares/sangre , Animales , Recolección de Muestras de Sangre/efectos adversos , Creatina Quinasa/sangre , Femenino , Masculino , Enfermedades Neuromusculares/metabolismo , Ratas , Ratas Endogámicas , Refrigeración , Caracteres Sexuales , Manejo de Especímenes/efectos adversos , Temperatura
3.
J Med Genet ; 33(3): 221-3, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8728695

RESUMEN

DNA samples from 231 unselected patients with cataracts were studied to determine the frequency of the DM mutation in cataract patients. A previous epidemiological study established a high prevalence of DM in the population of Guipúzcoa (Basque Country, Spain), 26.5 cases/100,000. We have found two carriers (0.9%) of the DM mutation in patients who are not related to any previously known DM family. The screening of the DM mutation in cataract patients should be restricted to young patients or people with multicoloured and iridescent opacities, in which the risk of carrying the DM premutation could be higher. Our results suggest that subjects with 38 to 80 repeats could constitute the genetic reservoir of the DM mutation.


Asunto(s)
Catarata/genética , Tamización de Portadores Genéticos , Distrofia Miotónica/genética , Secuencias Repetitivas de Ácidos Nucleicos , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Análisis de Varianza , ADN/sangre , Diabetes Mellitus/epidemiología , Retinopatía Diabética/epidemiología , Retinopatía Diabética/genética , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Distrofia Miotónica/epidemiología , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Caracteres Sexuales , Factores Sexuales , España/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA